Cooper ROE 2006-2018 | COO

Current and historical return on equity (ROE) values for Cooper (COO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Cooper ROE for the three months ending July 31, 2018 was 17.53%.
Cooper ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-07-31 $0.13B $3.23B 4.02%
2018-04-30 $0.13B $3.19B 4.15%
2018-01-31 $0.18B $3.16B 5.66%
2017-10-31 $0.37B $3.18B 12.44%
2017-07-31 $0.35B $3.09B 11.98%
2017-04-30 $0.33B $2.94B 11.79%
2017-01-31 $0.30B $2.82B 10.88%
2016-10-31 $0.27B $2.70B 10.16%
2016-07-31 $0.25B $2.74B 9.29%
2016-04-30 $0.21B $2.75B 7.72%
2016-01-31 $0.19B $2.61B 7.33%
2015-10-31 $0.20B $2.67B 7.77%
2015-07-31 $0.20B $2.69B 7.60%
2015-04-30 $0.24B $2.62B 9.27%
2015-01-31 $0.26B $2.52B 10.02%
2014-10-31 $0.27B $2.59B 10.51%
2014-07-31 $0.30B $2.68B 11.71%
2014-04-30 $0.30B $2.56B 12.03%
2014-01-31 $0.29B $2.45B 12.14%
2013-10-31 $0.30B $2.42B 12.53%
2013-07-31 $0.31B $2.44B 13.47%
2013-04-30 $0.29B $2.34B 12.99%
2013-01-31 $0.27B $2.25B 12.51%
2012-10-31 $0.25B $2.21B 12.02%
2012-07-31 $0.23B $2.10B 11.69%
2012-04-30 $0.21B $2.04B 10.82%
2012-01-31 $0.19B $1.94B 10.09%
2011-10-31 $0.18B $1.94B 9.51%
2011-07-31 $0.17B $1.89B 9.37%
2011-04-30 $0.16B $1.81B 9.54%
2011-01-31 $0.13B $1.72B 8.03%
2010-10-31 $0.11B $1.67B 7.05%
2010-07-31 $0.09B $1.59B 6.04%
2010-04-30 $0.08B $1.54B 4.94%
2010-01-31 $0.10B $1.55B 6.43%
2009-10-31 $0.10B $1.54B 6.89%
2009-07-31 $0.10B $1.51B 6.90%
2009-04-30 $0.10B $1.43B 6.64%
2009-01-31 $0.08B $1.38B 5.66%
2008-10-31 $0.06B $1.42B 4.44%
2008-07-31 $0.01B $1.50B 0.83%
2008-04-30 $0.00B $1.43B 0.14%
2008-01-31 $-0.01B $1.41B -0.70%
2007-10-31 $-0.01B $1.46B -0.84%
2007-07-31 $0.03B $1.44B 1.85%
2007-04-30 $0.04B $1.42B 2.81%
2007-01-31 $0.05B $1.40B 3.95%
2006-10-31 $0.07B $1.38B 4.99%
2006-07-31 $0.06B $1.36B 4.71%
2006-04-30 $0.08B $1.33B 6.12%
2006-01-31 $0.09B $1.30B 7.34%
2005-10-31 $0.09B $1.27B 7.48%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.619B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.125B 22.19
McKesson (MCK) United States $24.655B 9.42
AmerisourceBergen (ABC) United States $19.649B 14.02
Align Technology (ALGN) United States $16.351B 41.72
Laboratory Of America Holdings (LH) United States $16.316B 14.77
Cardinal Health (CAH) United States $16.259B 10.91
Henry Schein (HSIC) United States $13.148B 21.62
DENTSPLY SIRONA (XRAY) United States $8.216B 16.41
West Pharmaceutical Services (WST) United States $7.807B 38.75
Merit Medical Systems (MMSI) United States $3.226B 38.20
Patterson (PDCO) United States $2.438B 17.13
CONMED (CNMD) United States $1.901B 31.58
STAAR Surgical (STAA) United States $1.607B 165.48
Atrion (ATRI) United States $1.338B 38.25
Antares Pharma (ATRS) United States $0.520B 0.00
Invacare (IVC) United States $0.184B 0.00
Lifevantage (LFVN) United States $0.161B 22.80
Endologix (ELGX) United States $0.098B 0.00
Pro-Dex (PDEX) United States $0.060B 26.79
Aceto (ACET) United States $0.056B 0.00
Biolase (BIOL) United States $0.026B 0.00
Retractable Technologies (RVP) United States $0.022B 0.00
Milestone Scientific (MLSS) United States $0.020B 0.00